SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-035315
Filing Date
2022-11-07
Accepted
2022-11-07 20:26:02
Documents
2
Period of Report
2022-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 20930
2 EX-24 DOCUMENT attachment1.htm EX-24 4072
  Complete submission text file 0000899243-22-035315.txt   26432
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LIGAND PHARMACEUTICALS INC 3911 SORRENTO VALLEY BOULEVARD, STE 110 SAN DIEGO CA 92121
Business Address
Espinoza Octavio (Reporting) CIK: 0001905248 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33093 | Film No.: 221366923